1. US Food and Drug Administration, Orphan Drug Act—Relevant Excerpts: fda.gov/ForIndustry/DevelopingProductsforRareDiseasesConditions/HowtoapplyforOrphanProductDesignation/ucm364750.htm. Accessed 05.09.16.
2. European Medicines Agency, Orphan designation: ema.europa.eu/ema/index.jsp?curl=pages/regulation/general/general_content_000029.jsp&mid=WC0b01ac05800240ce. Accessed 05.9.16.
3. Physician and patient perceptions regarding physician training in rare diseases: the need for stronger educational initiatives for physicians;Engel;J Rare Dis,2013
4. The Rare Diseases Act 2002: www.congress.gov/107/plaws/publ280/PLAW-107publ280.pdf. Accessed 25.09.16.
5. A new initiative on precision medicine;Collins;N Engl J Med,2015